Student Spotlight


Gwen Gunn

Project Title: Assessing novel suppression and combination therapies for the treatment of MPS I-H
David Bedwell, PhD
Department: Microbiology
Undergrad: BS, University of Maryland, College Park

Welcome to the Cell, Molecular, and Developmental Biology (CMDB) PhD Theme, a part of the Graduate Biomedical Sciences program at the University of Alabama at Birmingham School of Medicine. The CMDB theme is designed to provide maximum flexibility that results in students who are prepared to launch into a career in the emerging biomedical science field. Our graduates have exciting careers in scientific research in both academic and industrial settings; scientific-related writing, business, law, bioterrorism, forensics, administration, and education. 

About Us: CMDB is a cross-disciplinary theme at a leading research University in the sunny south, consisting of a diverse group of scientists and physicians who have a collective interest in fundamental processes in cell, molecular, and developmental biology and how alterations in these processes result inhuman diseases and birth defects.

About UAB: We are consistently one of the top 25 NIH funded research institutions in the U.S. and with faculty from over 30 departments across campus there are many opportunities for you in new and exciting areas of biomedical research. And, UAB is a leader in innovative technology such as whole genome sequencing, electron microscopy, mass spectrometry, crystallography, flow cytometry, drug discovery and others.

Contact Us: We are always searching for the brightest and most dedicated students to join our highly competitive CMDB theme and experience firsthand our cutting edge science. This is your personal invitation to explore the many possible opportunities offered by CMDB at UAB. Please explore this web site and apply today!
No events found
  • Foods high in fats have long been put into the “unhealthy” category by nutrition experts, but UAB researchers believe this may have been all wrong, all along.For decades, the thought process behind “eating right” has been to focus on consuming a low-fat diet. But nutritional researchers at the University of Alabama at Birmingham say, when it comes to affecting body composition, this might be all wrong. Nutrition Obesity Research Center researchers Kevin Fontaine, Ph.D., and Amy Goss, Ph.D., are testing effects of diet quality on different outcomes. They are enrolling participants who are 60 years or older and obese, meaning they have a BMI of 30-plus. The participants will take part in a two-month dietary intervention in which they will be randomized to either a lower-carbohydrate/higher-fat diet or a low-fat/high-carbohydrate diet group. “We’re looking at a diet low in carbohydrates and higher in fat compared to a low-fat, higher-carbohydrate diet — the...

  • Convergence insufficiency can be mistaken for attention deficit disorder because the inability to focus eyesight can lead to reading and attention problems.Kristine Hopkins and pediatric clinic patient. Photo by Nik Layman.Convergence insufficiency — the inability to keep both eyes working together — causes difficulties in the classroom for children and is often mistaken for attention deficit disorder due to an overlap in behaviors. The University of Alabama at Birmingham School of Optometry is part of a multicenter clinical trial to determine what effects treatment of convergence insufficiency may have on reading comprehension and attention in these children. UAB is one of eight centers taking part in the convergence insufficiency treatment trial (CITT) study funded by an $8 million five-year grant from the National Institutes of Health’s National Eye Institute. “Children spend 75 percent of their school day reading and doing close work,” said Kristine Hopkins, O.D., MSPH, associate professor of optometry and site...

  • A UAB researcher focusing on the epigenetics of drug abuse wins a significant funding award from the National Institutes of Health.Jeremy DayJeremy J. Day, Ph.D., assistant professor in the Department of Neurobiology at the University of Alabama at Birmingham, has been named one of six inaugural recipients of new research awards from the National Institute on Drug Abuse. The Avenir Award programs in HIV/AIDS and epigenetics are newly developed programs that reward early-stage investigators who propose highly innovative studies. Avenir means ‘future’ in French. The Avenir Award Program for Genetics or Epigenetics of Substance Abuse supports early-stage investigators who show promise of being tomorrow’s leaders in the field of genetics or epigenetics of substance abuse. Epigenetics is an emerging field that studies how environmental factors influence changes in gene expression without altering the DNA sequence. Day says his proposal examines exposure to drugs of abuse, which produce long-lasting changes in neuronal circuits...

Epi Menu